The report entitled, Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the evaluation of more than 90 companies. The report analyzes established and new antibody-drug conjugate (ADC) technologies, business activities and opportunities and assesses more than 100 ADC development and research programs. The commercial value of ADC technologies, ADC products and ADC product candidates is described and valued by means of sales, product prices, company market capitalization, initial public offerings, venture capital and private equity financing, infrastructure investments and financial deal terms. Business deal activities in form of ...view middle of the document...
The stakeholder analysis compares companies with their peers in the respective group of development, technology and manufacturing companies and further categorizes them within the respective group to find out their competitive situation.
The analysis pays special attention to the importance of target selection, to emerging trends of new targeting moieties beyond full-length, canonical antibodies, to the expansion of the use of ADCs in non-cancer indications, to the opportunities arising from new site-specific and from polymer/nanoparticel-based conjugation systems and the most promising new payloads for ADCs.
Critical issues of ADCs, such as therapeutic window, druggable targets, manufacturing and financing are addressed and opportunities outlined.
Who will benefit from the report?
Business & Competitive Intelligence Analysts
What will you find in the report?
Company profiles of ADC stakeholders
ADC drug profiles
ADC business agreements
ADC pipeline description and analysis
Clinical attrition rate of ADCs and reasons for failure
ADC target description and analysis
Current and future drugs, linkers and conjugation systems
Industry preferences for drugs and linkers
Alternative targeting moieties
New uses of ADCs and immunoconjugates
CMOs for manufacturing of ADCs
Competitors in development, technology or manufacturing
Commercial value of ADC products and technologies
The information contained in this report is based on...